BractonDeal Intel
Get full access
AcquisitionOther

APPLIED GENETIC TECHNOLOGIES CORP acquired Applied Genetic Technologies Corporation Upfront consideration

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

APPLIED GENETIC TECHNOLOGIES CORP -> Applied Genetic Technologies Corporation Upfront consideration · $0.34

“This transaction represents an attractive upfront cash offer to shareholders at a premium of approximately 42% to the current share price, with the potential to receive future upside based on the clinical success of XLRP and other pipeline assets through CVRs

Open source record (SEC) ↗